UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

Journal of clinical lipidology, 2015-11, Vol.9 (6), p.758-769

2015

Volltextzugriff (PDF)

Obesity, cholesterol metabolism, and breast cancer pathogenesis

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (18), p.4976-4982

2014

Volltextzugriff (PDF)

Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task Force

The American journal of cardiology, 2006-04, Vol.97 (8), p.S89-S94

2006

Volltextzugriff (PDF)

Safety Considerations with Niacin Therapy

The American journal of cardiology, 2007-03, Vol.99 (6), p.S22-S31

2007

Volltextzugriff (PDF)

An assessment by the Statin Intolerance Panel: 2014 update

Journal of clinical lipidology, 2014-05, Vol.8 (3), p.S72-S81

2014

Volltextzugriff (PDF)

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

Journal of clinical lipidology, 2014-11, Vol.8 (6), p.554-561

2014

Volltextzugriff (PDF)

Metabolic syndrome: Definition, pathophysiology, and mechanisms

American heart journal, 2005, Vol.149 (1), p.33-45

2005

Volltextzugriff (PDF)

Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury

Experimental neurology, 2007-07, Vol.206 (1), p.59-69

2007

Volltextzugriff (PDF)

From the editor: Transition of leadership for JCL

Journal of clinical lipidology, 2023-05, Vol.17 (3), p.307-308

Guyton, John R.

2023

Volltextzugriff (PDF)

From the editor: The role of generalists in clinical lipidology

Journal of clinical lipidology, 2023-03, Vol.17 (2), p.197-197

Guyton, John R.

2023

Volltextzugriff (PDF)

From the editor: Intensive exercise and insights from women

Journal of clinical lipidology, 2023-01, Vol.17 (1), p.1-2

Guyton, John R.

2023

Volltextzugriff (PDF)

From the editor: A compendium of lipidology progress

Journal of clinical lipidology, 2022-11, Vol.16 (6), p.761-762

Guyton, John R.

2022

Volltextzugriff (PDF)

Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia

Journal of clinical lipidology, 2016-07, Vol.10 (4), p.905-914

2016

Volltextzugriff (PDF)

Niacin, food intake and cardiovascular effects

Nature medicine, 2024-09, Vol.30 (9), p.2444-2445

2024

Volltextzugriff (PDF)

Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)

The American journal of cardiology, 2017-02, Vol.119 (3), p.397-403

2017

Volltextzugriff (PDF)

From the editor: Lipidology resurgent as the pandemic wanes

Journal of clinical lipidology, 2022-09, Vol.16 (5), p.545-545

Guyton, John R.

2022

Volltextzugriff (PDF)

From the editor: A time of renewal for clinical lipidology

Journal of clinical lipidology, 2022-07, Vol.16 (4), p.359-359

Guyton, John R.

2022

Volltextzugriff (PDF)

From the editor: Eglerio! The Ringbearers, praise them

Journal of clinical lipidology, 2022-05, Vol.16 (3), p.247-248

Guyton, John R.

2022

Volltextzugriff (PDF)

From the editor: Hope and strength in community

Journal of clinical lipidology, 2022-03, Vol.16 (2), p.113-113

Guyton, John R.

2022

Volltextzugriff (PDF)

From the editor: Heroes in a historic time

Journal of clinical lipidology, 2022-01, Vol.16 (1), p.1-1

Guyton, John R.

2022

Volltextzugriff (PDF)

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

Journal of the American College of Cardiology, 2008-04, Vol.51 (16), p.1564-1572

2008

Volltextzugriff (PDF)

From the editor: Trust and the value paradox in science

Journal of clinical lipidology, 2021-11, Vol.15 (6), p.761-762

Guyton, John R.

2021

Volltextzugriff (PDF)

Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study

PLoS genetics, 2010-04, Vol.6 (4), p.e1000928-e1000928

2010

Volltextzugriff (PDF)

From the editor: Coyotes on the lawn

Journal of clinical lipidology, 2021-09, Vol.15 (5), p.619-619

Guyton, John R.

2021

Volltextzugriff (PDF)

From the editor: Prevention then and now

Journal of clinical lipidology, 2021-07, Vol.15 (4), p.527-527

Guyton, John R.

2021

Volltextzugriff (PDF)

1 – 25 von 437

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(408)
Mit Volltextzugriff
(399)

Publikationsform

Sprache

Englisch
(435)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(299)
Life Sciences & Biomedicine
(295)
Humans
(229)
Cardiovascular System & Cardiology
(175)
Cardiac & Cardiovascular Systems
(166)
Male
(120)
Female
(116)
Biological And Medical Sciences
(106)
Medical Sciences
(102)
Middle Aged
(87)
Surgery
(84)
Respiratory System
(69)
Aged
(65)
Pharmacology & Pharmacy
(65)
Cardiovascular
(55)
Cardiology. Vascular System
(54)
Animals
(50)
Treatment Outcome
(50)
Risk Factors
(48)
Peripheral Vascular Disease
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

Obesity, cholesterol metabolism, and breast cancer pathogenesis

Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task Force

Safety Considerations with Niacin Therapy

An assessment by the Statin Intolerance Panel: 2014 update

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

Metabolic syndrome: Definition, pathophysiology, and mechanisms

Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury

From the editor: Transition of leadership for JCL

From the editor: The role of generalists in clinical lipidology

From the editor: Intensive exercise and insights from women

From the editor: A compendium of lipidology progress

Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia

Niacin, food intake and cardiovascular effects

Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)

From the editor: Lipidology resurgent as the pandemic wanes

From the editor: A time of renewal for clinical lipidology

From the editor: Eglerio! The Ringbearers, praise them

From the editor: Hope and strength in community

From the editor: Heroes in a historic time

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

From the editor: Trust and the value paradox in science

Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study

From the editor: Coyotes on the lawn

From the editor: Prevention then and now

Suchergebnisse filtern